Transient response to nivolumab and relapse after infliximab in a patient with primary cutaneous CD8‐positive aggressive epidermotropic cytotoxic T‐cell lymphoma

F Toussaint, M Erdmann, E Grosch, S Schliep, G Schuler, R Dummer, L Heinzerling
2021
doi:10.5167/uzh-201253 fatcat:7fhgh6g7n5hsjkjub3t6ipujam